The government, eager to protect the UK's standing as an innovator of world - leading
global medicines, is investing heavily in the life sciences, with initiatives such as the NIHR
Office for Clinical Research and Infrastructure (NOCRI) promoting the UK as a preferred
destination for clinical research.